2m 2m 2m 2m 2m 2m 2m
Biocryst Pharm (BCRX)
NASDAQ
$9.10+$0.12 (+1.33%)
Price as of Aug 03, 2026 8:46 AM EDT- $2.3BMarket Cap
- 12.96%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Biocryst Pharm (BCRX)
$9.10+$0.12 (+1.33%)
BCRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.98 | ||
Change | -$0.26 (-2.81%) | ||
Open | $9.17 | ||
High | $9.25 | ||
Low | $8.93 | ||
Previous Close | $9.24 | ||
Volume | 2,929,185 | ||
30-Day Average Volume | 3,874,028 | ||
1-Week Change | -3.85% | ||
1-Month Change | -10.20% | ||
1-Year Change | 12.96% | ||
3-Year Change | 21.52% | ||
5-Year Change | -44.29% | ||
Fundamentals | |||
Shares Outstanding | 254.2M | ||
Total Assets | $465.1M | ||
Market Cap | $2.3B | ||
Enterprise Value | $2.5B | ||
Period: QTR TTM FY | |||
Revenue | $151.4M | ||
Net Income | -$721.8M | ||
Free Cash Flow | -$62.2M | ||
EBIT | -$714.6M | ||
EBITDA | -$714.0M | ||
Net Working Capital | $178.2M | ||
EPS | -$2.98 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | 17 | ||
P/B | -4 | ||
P/E | -3 | ||
PEG | 0 | ||
Price/Free Cash Flow | -37 | ||
Price/Operating Cash Flow | -37 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue